CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Deep NMB using rocuronium +1 moredrug
Likely dose
Deep NMB using rocuronium 0.7 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03266419
NCT03266419N/ACompleted
CompareCT.gov

A Double-blind, Randomized, Parallel Design to Compare the Effectiveness of Deep Versus Moderate Neuromuscular Blockade With Standard-pressure Pneumoperitoneum During Laparoscopic Gastrectomy on Postoperative Pain in Surgical Patients

Asan Medical Center·interventional·Posted Aug 30, 2017·Updated Nov 13, 2019

In Brief

A clinical study evaluating Deep NMB using rocuronium and Moderate NMB using rocuronium for Neuromuscular Blockade. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The aim of this study is to evaluate the influence of depth of neuromuscular blockade during laparoscopic gastrectomy on postoperative pain in surgical patients allocated randomly to either deep or moderate neuromuscular blockade group with standard-pressure pneumoperitoneum of 13 mmHg.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuromuscular Blockade
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 30, 2017
Enrollment StartMar 28, 2018
Primary CompletionNov 1, 2018
Study CompletionNov 2, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.8 years ago

Interventions

Deep NMB using rocuroniumdrug

* Drug: rocuronium * Bolus dose: 0.7 mg/kg * Continuous infusion : 0.8-1.2 mg/kg/h for maintaining deep NMB (post tetanic count 1-2) during operation.

Moderate NMB using rocuroniumdrug

* Drug: rocuronium * Bolus dose: none * Continuous infusion: 0.2-0.6 mg/kg/h for maintaining moderate NMB (train of four 1-2) during operation.